| Title | Author(s) | Issue date | ???itemlist.??? |
| Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG) | Nicolaides, C.; Klouvas, G.; Fountzilas, G.; Athanassiadis, A.; Skarlos, D.; Samantas, E.; Kosmidis, P.; Mylonakis, N.; Pavlidis, N. | 24-Nov-2015 | - |
| Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study | Kosmidis, P.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanassiadis, A.; Pavlidis, N.; Skarlos, D. | 24-Nov-2015 | - |
| Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Athanassiadis, A.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Briasoulis, E.; Dombros, N.; Ioannidis, I.; Pavlidis, N.; Kosmidis, P.; Skarlos, D. | 24-Nov-2015 | - |
| Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study | Skarlos, D. V.; Aravantinos, G.; Kosmidis, P.; Athanassiadis, A.; Stathopoulos, G. P.; Pavlidis, N.; Bafaloukos, D.; Karphathios, S.; Papakostas, P.; Bamia, C.; Fountzilas, G. | 24-Nov-2015 | - |
| Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safety | Pentheroudakis, G.; Razis, E.; Athanassiadis, A.; Pavlidis, N.; Fountzilas, G. | 24-Nov-2015 | - |
| Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group Study | Pavlidis, N.; Nicolaides, C.; Athanassiadis, A.; Beriatou, K.; Skarlos, D.; Giannakakis, T.; Kosmidis, P.; Karvounis, N.; Fountzilas, G. | 24-Nov-2015 | - |
| The role of soluble interleukin-2 (SIL-2R) receptors as a tumor marker in patients with advanced colorectal cancer (ACC) | Pavlidis, N.; Bairaktari, E.; Nicolaides, C.; KalefEzra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G. | 24-Nov-2015 | - |
| Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma | Pavlidis, N.; Nicolaides, C.; Bairaktari, E.; Kalef-Ezra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G. | 24-Nov-2015 | - |
| Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma | Pavlidis, N.; Nicolaides, C.; Bairaktari, E.; KalefEzra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G. | 24-Nov-2015 | - |
| Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin | Nicolaides, C.; Giannakakis, T.; Skarlos, D.; Athanassiadis, A.; Fountzilas, G.; Damigos, D.; Pavlidis, N. | 24-Nov-2015 | - |
